FDA
label_change
· 2019-10-04
FDA Approved: AIMOVIG — Supplemental Application (Amgen Inc)
Summary
The FDA approved a supplemental application for Aimovig (erenumab-aooe) from Amgen to update the product’s labeling.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for AIMOVIG (ERENUMAB-AOOE)